Intra-individual comparison of p-[123I]-iodo-L-phenylalanine and L-3-[123I]-iodo-α-methyl-tyrosine for SPECT imaging of gliomas

European Journal of Nuclear Medicine and Molecular Imaging

Volumn 35, Issue 1, 2008, Pages 24-31

  Hellwig, Dirk ^a   Romeike, Bernd F M ^a,b   Ketter, Ralf ^a   Moringlane, Jean R ^a   Kirsch, Carl Martin ^a   Samnick, Samuel ^a  

^a SAARLAND UNIVERSITY   (Germany)

^b FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

Amino acids; Brain neoplasms; Comparative study; Radiopharmaceuticals; Tomography, Emission computed, Single photon

Indexed keywords

3 IODO ALPHA METHYL TYROSINE I 123; 4 IODOPHENYLALANINE I 123; RADIOPHARMACEUTICAL AGENT; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; CANCER PATIENT; CELL DENSITY; CLINICAL ARTICLE; CONTROLLED STUDY; DRUG ACCUMULATION; DRUG DISTRIBUTION; FEMALE; GLIOMA; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; MALE; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; TUMOR CELL;

ADULT; AGED; BRAIN; BRAIN NEOPLASMS; CELL COUNT; FEMALE; GLIOMA; HUMANS; MALE; METHYLTYROSINES; MIDDLE AGED; PHENYLALANINE; RADIOPHARMACEUTICALS; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON;

EID: 36849064228     PISSN: 16197070     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00259-007-0514-2     Document Type: Article

References (31)

1. Bénard F, Romsa J, Hustinx R. Imaging gliomas with positron emission tomography and single-photon emission computed tomography. Semin Nucl Med 2003; 33:148-62.
2. Weber WA, Wester HJ, Grosu AL, Herz M, Dzewas B, Feldmann HJ, et al. O-(2-[18F]fluoroethyl)-L-tyrosine and L-[methyl-11C]methionine uptake in brain tumours: initial results of a comparative study. Eur J Nucl Med 2000; 27:542-9.
3. Pauleit D, Floeth F, Hamacher K, Riemenschneider MJ, Reifenberger G, Muller HW, et al. O-(2-[18F]fluoroethyl)-L-tyrosine PET combined with MRI improves the diagnostic assessment of cerebral gliomas. Brain 2005; 128:678-87.
4. Biersack HJ, Coenen HH, Stöcklin G, Reichmann K, Bockisch A, Oehr P, et al. Imaging of brain tumors with L-3-[123I]iodo-alpha-methyl tyrosine and SPECT. J Nucl Med 1989; 30:110-2.
5. Grosu AL, Feldmann H, Dick S, Dzewas B, Nieder C, Gumprecht H, et al. Implications of IMT-SPECT for postoperative radiotherapy planning in patients with gliomas. Int J Radiat Oncol Biol Phys 2002; 54:842-54.
6. Weckesser M, Griessmeier M, Schmidt D, Sonnenberg F, Ziemons K, Kemna L, et al. Iodine-123 alpha-methyl tyrosine single-photon emission tomography of cerebral gliomas: standardised evaluation of tumour uptake and extent. Eur J Nucl Med 1998; 25:150-6.
7. Kuwert T, Morgenroth C, Woesler B, Matheja P, Palkovic S, Vollet B, et al. Uptake of iodine-123-alpha-methyl tyrosine by gliomas and non-neoplastic brain lesions. Eur J Nucl Med 1996; 23:1345-53.
8. Matheja P, Rickert C, Weckesser M, Palkovic S, Lottgen J, Riemann B, et al. Sequential scintigraphic strategy for the differentiation of brain tumours. Eur J Nucl Med 2000; 27:550-8.
9. Woesler B, Kuwert T, Morgenroth C, Matheja P, Palkovic S, Schäfers M, et al. Non-invasive grading of primary brain tumours: results of a comparative study between SPET with 123I-alpha-methyl tyrosine and PET with 18F-deoxyglucose. Eur J Nucl Med 1997; 24:428-34.
10. Riemann B, Papke K, Hoess N, Kuwert T, Weckesser M, Matheja P, et al. Noninvasive grading of untreated gliomas: a comparative study of MR imaging and 3-(iodine 123)-L-alpha-methyltyrosine SPECT. Radiology 2002; 225:567-74.
11. Weber WA, Dick S, Reidl G, Dzewas B, Busch R, Feldmann HJ, et al. Correlation between postoperative 3-[(123)I]iodo-L-alpha-methyltyrosine uptake and survival in patients with gliomas. J Nucl Med 2001; 42:1144-50.
12. Samnick S, Bader JB, Hellwig D, Moringlane JR, Alexander C, Romeike BF, et al. Clinical value of iodine-123-alpha-methyl-L-tyrosine single-photon emission tomography in the differential diagnosis of recurrent brain tumor in patients pretreated for glioma at follow-up. J Clin Oncol 2002; 20:396-404.
13. Kuwert T, Woesler B, Morgenroth C, Lerch H, Schafers M, Palkovic S, et al. Diagnosis of recurrent glioma with SPECT and iodine-123-alpha-methyl tyrosine. J Nucl Med 1998; 39:23-7.
14. Bader JB, Samnick S, Moringlane JR, Feiden W, Schaefer A, Kremp S, et al. Evaluation of l-3-[123I]iodo-alpha-methyltyrosine SPET and [18F] fluorodeoxyglucose PET in the detection and grading of recurrences in patients pretreated for gliomas at follow-up: a comparative study with stereotactic biopsy. Eur J Nucl Med 1999; 26:144-51.
15. Langen KJ, Coenen HH, Roosen N, Kling P, Muzik O, Herzog H, et al. SPECT studies of brain tumors with L-3-[123I] iodo-alpha-methyl tyrosine: comparison with PET, 124IMT and first clinical results. J Nucl Med 1990; 31:281-6.
16. Samnick S, Richter S, Romeike BF, Heimann A, Feiden W, Kempski O, et al. Investigation of iodine-123-labelled amino acid derivatives for imaging cerebral gliomas: uptake in human glioma cells and evaluation in stereotactically implanted C6 glioma rats. Eur J Nucl Med 2000; 27:1543-51.
17. Samnick S, Schaefer A, Siebert S, Richter S, Vollmar B, Kirsch CM. Preparation and investigation of tumor affinity, uptake kinetic and transport mechanism of iodine-123-labelled amino acid derivatives in human pancreatic carcinoma and glioblastoma cells. Nucl Med Biol 2001; 28:13-23.
18. Samnick S, Hellwig D, Bader JB, Romeike BF, Moringlane JR, Feiden W, et al. Initial evaluation of the feasibility of single photon emission tomography with p-[123I]iodo-L-phenylalanine for routine brain tumour imaging. Nucl Med Commun 2002; 23:121-30.
19. Hellwig D, Ketter R, Romeike BF, Sell N, Schaefer A, Moringlane JR, et al. Validation of brain tumour imaging with p-[(123)I]iodo-L-phenylalanine and SPECT. Eur J Nucl Med Mol Imaging 2005; 32:1041-9.
20. Schmidt D, Langen KJ, Herzog H, Wirths J, Holschbach M, Kiwit JC, et al. Whole-body kinetics and dosimetry of L-3-123I-iodo-alpha-methyltyrosine. Eur J Nucl Med 1997; 24:1162-6.
21. Hudson HM, Larkin RS. Accelerated image reconstruction using ordered subsets of projection data. IEEE Trans Med Imaging 1994; 13:601-9.
22. Chang LT. A method for attenuation correction in radionuclide computer tomography. IEEE Trans Nucl Sci 1978; 26:2780-9.
23. Maes F, Collignon A, Vandermeulen D, Marchal G, Suetens P. Multimodality image registration by maximization of mutual information. IEEE Trans Med Imaging 1997; 16:187-98.
24. Thurfjell L, Lau YH, Andersson JL, Hutton BF. Improved efficiency for MRI-SPET registration based on mutual information. Eur J Nucl Med 2000; 27:847-56.
25. Kleihues P, Cavenee WK. Pathology and genetics of tumours of the central nervous system. Lyon: International Agency for Research on Cancer (IARC), Lyon, France, 2000.
26. Kim YJ, Romeike BF, Uszkoreit J, Feiden W. Automated nuclear segmentation in the determination of the Ki-67 labeling index in meningiomas. Clin Neuropathol 2006; 25:67-73.
27. Vander Borght T, Asenbaum S, Bartenstein P, Halldin C, Kapucu O, Van Laere K, et al. EANM procedure guidelines for brain tumour imaging using labelled amino acid analogues. Eur J Nucl Med Mol Imaging 2006; 33:1374-80.
28. Plotkin M, Eisenacher J, Bruhn H, Wurm R, Michel R, Stockhammer F, et al. 123I-IMT SPECT and 1H MR-spectroscopy at 3.0 T in the differential diagnosis of recurrent or residual gliomas: a comparative study. J Neurooncol 2004; 70:49-58.
29. Kuwert T, Probst-Cousin S, Woesler B, Morgenroth C, Lerch H, Matheja P, et al. Iodine-123-alpha-methyl tyrosine in gliomas: correlation with cellular density and proliferative activity. J Nucl Med 1997; 38:1551-5.
30. Defrise M, Gullberg GT. Image reconstruction. Phys Med Biol 2006; 51:R139-54.
31. Romeike BF, Hellwig D, Heimann A, Kempski O, Feiden W, Kirsch CM, et al. Action and efficacy of p-[131I]iodo-L-phenylalanine on primary human glioma cell cultures and rats with C6-gliomas. Anticancer Res 2004; 24:3971-6.